Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-08

Clinical Trial Update: Vulnerability and Risk of Neuropathic Pain in Cancer [NA]

View source ↗

Summary

An ongoing clinical trial led by University Hospital in Clermont-Ferrand is recruiting to study vulnerability and risk factors for developing neuropathic pain i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Neuropathic Pain, Cancer | NA | Status: RECRUITING